Mirna Sequencing And Assay Market
PUBLISHED: 2025 ID: SMRC28496
SHARE
SHARE

Mirna Sequencing And Assay Market

miRNA Sequencing and Assay Market Forecasts to 2030 - Global Analysis By Product Type (miRNA Analysis Software, miRNA Sequencing Services and Other Product Types), miRNA Type, Sample Type, Technology, Application, End User and By Geography

4.2 (79 reviews)
4.2 (79 reviews)
Published: 2025 ID: SMRC28496

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global miRNA Sequencing and Assay Market is accounted for $397.5 million in 2024 and is expected to reach $886.4 million by 2030 growing at a CAGR of 14.3% during the forecast period. miRNA sequencing is a high-throughput technique used to analyze microRNA (miRNA) expression profiles in a biological sample. It involves isolating and sequencing small RNA molecules to identify and quantify miRNAs, providing insights into gene regulation and cellular processes. miRNA assays are experimental methods to measure the abundance or activity of miRNAs, often using technologies like qRT-PCR, microarrays, or next-generation sequencing. These tools help in understanding the role of miRNAs in diseases, development, and cellular responses.
 
According to an article published in the National Center for Biotechnology Information (NCBI), in July 2021, early-stage diagnosis of COVID-19 may be identified with 99.9% accuracy by measuring miRNA (miR-195-5p, miR-23a-3p, and miR-423-5p).

Market Dynamics: 

Driver: 

Growing demand for personalized medicine

The growing demand for personalized medicine is driving the market, as miRNAs play a crucial role in gene regulation and disease mechanisms. By providing insights into individual genetic profiles, miRNA analysis enables targeted therapies and precision treatments. This shift towards personalized medicine fosters advancements in diagnostics, drug development, and patient-specific care, increasing the adoption of miRNA sequencing technologies for tailored healthcare solutions.

Restraint:

Complex data analysis

Complex data analysis in the market poses challenges such as high computational costs, the need for advanced bioinformatics expertise, and potential errors in data interpretation. These complexities can lead to inconsistencies, reduced reproducibility, and difficulties in extracting meaningful biological insights. As a result, it can slow down the adoption of miRNA-based diagnostics and therapies, hindering progress in personalized medicine and clinical applications.

Opportunity:

Increasing prevalence of chronic diseases

The increasing prevalence of chronic diseases is fueling the market, as miRNAs are involved in the regulation of various pathways associated with diseases like cancer, diabetes, and cardiovascular conditions. miRNA analysis helps in early diagnosis, monitoring disease progression, and developing personalized treatment plans. This rising demand for precise diagnostics and therapeutic strategies is driving the growth of miRNA sequencing technologies in chronic disease management and research.

Threat:

High cost of sequencing and analysis

The high cost of sequencing and analysis in the market limits accessibility, especially for smaller research labs and healthcare settings. This financial barrier hinders widespread adoption and implementation of miRNA-based diagnostics and therapies. Additionally, the expense can slow down the pace of research and innovation, delaying potential breakthroughs in personalized medicine and reducing opportunities for improving patient outcomes across various diseases.

Covid-19 Impact: 

The COVID-19 pandemic disrupted the market by delaying research projects, limiting laboratory access, and diverting resources toward immediate pandemic-related needs. This caused setbacks in ongoing studies and hindered the development of miRNA-based diagnostics and treatments. However, the pandemic also highlighted the importance of rapid, precise diagnostics, accelerating interest in miRNA technologies for viral infection detection and personalized therapeutic approaches in future global health crises.

The autoimmune disease segment is expected to be the largest during the forecast period

The autoimmune disease segment is expected to account for the largest market share during the forecast period. miRNAs are being studied as potential biomarkers for autoimmune disorders like lupus, and multiple sclerosis. miRNA profiling aids in understanding disease mechanisms, identifying therapeutic targets, and developing early diagnostic tools. As research advances, miRNA-based assays are expected to play a key role in the personalized treatment of autoimmune diseases, enhancing diagnostic accuracy and therapeutic efficacy.

The pharmaceutical and biotechnology companies segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pharmaceutical and biotechnology companies segment is predicted to witness the highest growth rate. miRNAs play a crucial role in gene regulation, and their expression profiles can reveal insights into various diseases, including cancer and neurological disorders. Advances in sequencing technologies enable high-throughput analysis of miRNA expression, offering potential for novel therapeutic approaches and improving patient-specific treatment strategies in the pharmaceutical market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share driven by advanced healthcare infrastructureand a strong focus on personalized medicine. The region benefits from widespread adoption of miRNA technologies in both academic and clinical settings, with ongoing advancements in cancer research, infectious diseases, and genetic disorders. Government funding, along with collaborations between biotech companies and research institutions, further supports the market's expansion.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. There is a growing investment in miRNA-based research, particularly in understanding their role in gene regulation, disease mechanisms, and therapeutic applications. Additionally, The shift toward personalized and precision medicine is boosting the demand for miRNA sequencing, as miRNAs can offer valuable insights into individual genetic profiles and disease susceptibility.

Key players in the market

Some of the key players in miRNA Sequencing and Assay market include Illumina, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Agilent Technologies, Inc., Macrogen, Inc., Bio-Rad Laboratories, Inc., Takara Bio, Inc., Exiqon A/S, Zymo Research Corporation, New England Biolabs, Inc., Roche Diagnostics, Promega Corporation, Luminex Corporation, Boster Biological Technology, and Bioo Scientific.

Key Developments:

In November 2024, QIAGEN announced the launch of two new tools for designing and ordering custom solutions that can be used to support microbial analysis of bacterial, fungal and viral targets. hese new tools enable researchers to customize their assays and panels for use on the QIAcuity digital PCR system as well as on any third-party next-generation sequencing (NGS) system.

In September 2024, QIAGEN announced an important milestone with the launch of 100 new assays for its digital PCR (dPCR) platform QIAcuity for use in the study of cancer, inherited genetic disorders, infectious disease surveillance, and food and environmental monitoring.

Product Types Covered:
• miRNA Analysis Software 
• miRNA Sequencing Services
• Other Product Types

miRNA Types Covered:
• Conserved miRNAs
• Non-Conserved miRNAs
• OncomiRs
• Developmental miRNAs

Sample Types Covered:
• Blood/Serum/Plasma
• Tissue Samples
• Urine and Saliva
• Cell Lines

Technologies Covered:
• Sequencing
• Nanopore Sequencing
• Sanger Sequencing.
• Single Molecule Real-time (SMRT) Sequencing

Applications Covered:
• Cancer
• Polyglutamine Diseases
• Cardiovascular Diseases
• Schizophrenia
• Autoimmune Disease 
• Infectious Diseases
• Neurological Disorders
• Other Applications

End Users Covered:
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Hospitals and Diagnostic Laboratories
• Contract Research Organizations (CROs)
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary            
              
2 Preface             
 2.1 Abstract            
 2.2 Stake Holders           
 2.3 Research Scope           
 2.4 Research Methodology          
  2.4.1 Data Mining          
  2.4.2 Data Analysis          
  2.4.3 Data Validation          
  2.4.4 Research Approach          
 2.5 Research Sources           
  2.5.1 Primary Research Sources         
  2.5.2 Secondary Research Sources         
  2.5.3 Assumptions          
              
3 Market Trend Analysis           
 3.1 Introduction           
 3.2 Drivers            
 3.3 Restraints           
 3.4 Opportunities           
 3.5 Threats            
 3.6 Product Analysis           
 3.7 Technology Analysis          
 3.8 Application Analysis          
 3.9 End User Analysis           
 3.10 Emerging Markets           
 3.11 Impact of Covid-19           
              
4 Porters Five Force Analysis           
 4.1 Bargaining power of suppliers          
 4.2 Bargaining power of buyers          
 4.3 Threat of substitutes          
 4.4 Threat of new entrants          
 4.5 Competitive rivalry           
              
5 Global miRNA Sequencing and Assay Market, By Product Type       
 5.1 Introduction           
 5.2 miRNA Analysis Software          
  5.2.1 Sequencing Consumables         
  5.2.2 Library Preparation Kits         
 5.3 miRNA Sequencing Services          
 5.4 Other Product Types          
              
6 Global miRNA Sequencing and Assay Market, By miRNA Type        
 6.1 Introduction           
 6.2 Conserved miRNAs           
 6.3 Non-Conserved miRNAs          
 6.4 OncomiRs           
 6.5 Developmental miRNAs          
              
7 Global miRNA Sequencing and Assay Market, By Sample Type        
 7.1 Introduction           
 7.2 Blood/Serum/Plasma          
 7.3 Tissue Samples           
 7.4 Urine and Saliva           
 7.5 Cell Lines            
              
8 Global miRNA Sequencing and Assay Market, By Technology        
 8.1 Introduction           
 8.2 Sequencing           
  8.2.1 Next-Generation Sequencing (NGS)        
  8.2.2 Microarray          
  8.2.3 Quantitative Polymerase Chain Reaction (qPCR)       
 8.3 Nanopore Sequencing          
 8.4 Sanger Sequencing.           
 8.5 Single Molecule Real-time (SMRT) Sequencing        
              
9 Global miRNA Sequencing and Assay Market, By Application        
 9.1 Introduction           
 9.2 Cancer            
 9.3 Polyglutamine Diseases          
 9.4 Cardiovascular Diseases          
 9.5 Schizophrenia           
 9.6 Autoimmune Disease           
 9.7 Infectious Diseases           
 9.8 Neurological Disorders          
 9.9 Other Applications           
              
10 Global miRNA Sequencing and Assay Market, By End User        
 10.1 Introduction           
 10.2 Academic and Research Institutes         
 10.3 Pharmaceutical and Biotechnology Companies        
 10.4 Hospitals and Diagnostic Laboratories         
 10.5 Contract Research Organizations (CROs)         
 10.6 Other End Users           
              
11 Global miRNA Sequencing and Assay Market, By Geography        
 11.1 Introduction           
 11.2 North America           
  11.2.1 US           
  11.2.2 Canada           
  11.2.3 Mexico           
 11.3 Europe            
  11.3.1 Germany           
  11.3.2 UK           
  11.3.3 Italy           
  11.3.4 France           
  11.3.5 Spain           
  11.3.6 Rest of Europe          
 11.4 Asia Pacific           
  11.4.1 Japan           
  11.4.2 China           
  11.4.3 India           
  11.4.4 Australia           
  11.4.5 New Zealand          
  11.4.6 South Korea          
  11.4.7 Rest of Asia Pacific          
 11.5 South America           
  11.5.1 Argentina          
  11.5.2 Brazil           
  11.5.3 Chile           
  11.5.4 Rest of South America         
 11.6 Middle East & Africa          
  11.6.1 Saudi Arabia          
  11.6.2 UAE           
  11.6.3 Qatar           
  11.6.4 South Africa          
  11.6.5 Rest of Middle East & Africa         
              
12 Key Developments            
 12.1 Agreements, Partnerships, Collaborations and Joint Ventures       
 12.2 Acquisitions & Mergers          
 12.3 New Product Launch          
 12.4 Expansions           
 12.5 Other Key Strategies          
              
13 Company Profiling            
 13.1 Illumina, Inc.           
 13.2 Thermo Fisher Scientific, Inc.          
 13.3 Qiagen N.V.           
 13.4 Agilent Technologies, Inc.          
 13.5 Macrogen, Inc.           
 13.6 Bio-Rad Laboratories, Inc.          
 13.7 Takara Bio, Inc.           
 13.8 Exiqon A/S            
 13.9 Zymo Research Corporation          
 13.10 New England Biolabs, Inc.          
 13.11 Roche Diagnostics           
 13.12 Promega Corporation          
 13.13 Luminex Corporation          
 13.14 Boster Biological Technology          
 13.15 Bioo Scientific           
              
List of Tables             
1 Global miRNA Sequencing and Assay Market Outlook, By Region (2022-2030) ($MN)     
2 Global miRNA Sequencing and Assay Market Outlook, By Product Type (2022-2030) ($MN)     
3 Global miRNA Sequencing and Assay Market Outlook, By miRNA Analysis Software (2022-2030) ($MN)    
4 Global miRNA Sequencing and Assay Market Outlook, By Sequencing Consumables (2022-2030) ($MN)    
5 Global miRNA Sequencing and Assay Market Outlook, By Library Preparation Kits (2022-2030) ($MN)    
6 Global miRNA Sequencing and Assay Market Outlook, By miRNA Sequencing Services (2022-2030) ($MN)   
7 Global miRNA Sequencing and Assay Market Outlook, By Other Product Types (2022-2030) ($MN)    
8 Global miRNA Sequencing and Assay Market Outlook, By miRNA Type (2022-2030) ($MN)     
9 Global miRNA Sequencing and Assay Market Outlook, By Conserved miRNAs (2022-2030) ($MN)    
10 Global miRNA Sequencing and Assay Market Outlook, By Non-Conserved miRNAs (2022-2030) ($MN)    
11 Global miRNA Sequencing and Assay Market Outlook, By OncomiRs (2022-2030) ($MN)     
12 Global miRNA Sequencing and Assay Market Outlook, By Developmental miRNAs (2022-2030) ($MN)    
13 Global miRNA Sequencing and Assay Market Outlook, By Sample Type (2022-2030) ($MN)     
14 Global miRNA Sequencing and Assay Market Outlook, By Blood/Serum/Plasma (2022-2030) ($MN)    
15 Global miRNA Sequencing and Assay Market Outlook, By Tissue Samples (2022-2030) ($MN)     
16 Global miRNA Sequencing and Assay Market Outlook, By Urine and Saliva (2022-2030) ($MN)     
17 Global miRNA Sequencing and Assay Market Outlook, By Cell Lines (2022-2030) ($MN)     
18 Global miRNA Sequencing and Assay Market Outlook, By Technology (2022-2030) ($MN)     
19 Global miRNA Sequencing and Assay Market Outlook, By Sequencing (2022-2030) ($MN)     
20 Global miRNA Sequencing and Assay Market Outlook, By Next-Generation Sequencing (NGS) (2022-2030) ($MN)   
21 Global miRNA Sequencing and Assay Market Outlook, By Microarray (2022-2030) ($MN)     
22 Global miRNA Sequencing and Assay Market Outlook, By Quantitative Polymerase Chain Reaction (qPCR) (2022-2030) ($MN)  
23 Global miRNA Sequencing and Assay Market Outlook, By Nanopore Sequencing (2022-2030) ($MN)    
24 Global miRNA Sequencing and Assay Market Outlook, By Sanger Sequencing. (2022-2030) ($MN)    
25 Global miRNA Sequencing and Assay Market Outlook, By Single Molecule Real-time (SMRT) Sequencing (2022-2030) ($MN)  
26 Global miRNA Sequencing and Assay Market Outlook, By Application (2022-2030) ($MN)     
27 Global miRNA Sequencing and Assay Market Outlook, By Cancer (2022-2030) ($MN)     
28 Global miRNA Sequencing and Assay Market Outlook, By Polyglutamine Diseases (2022-2030) ($MN)    
29 Global miRNA Sequencing and Assay Market Outlook, By Cardiovascular Diseases (2022-2030) ($MN)    
30 Global miRNA Sequencing and Assay Market Outlook, By Schizophrenia (2022-2030) ($MN)     
31 Global miRNA Sequencing and Assay Market Outlook, By Autoimmune Disease (2022-2030) ($MN)    
32 Global miRNA Sequencing and Assay Market Outlook, By Infectious Diseases (2022-2030) ($MN)    
33 Global miRNA Sequencing and Assay Market Outlook, By Neurological Disorders (2022-2030) ($MN)    
34 Global miRNA Sequencing and Assay Market Outlook, By Other Applications (2022-2030) ($MN)    
35 Global miRNA Sequencing and Assay Market Outlook, By End User (2022-2030) ($MN)     
36 Global miRNA Sequencing and Assay Market Outlook, By Academic and Research Institutes (2022-2030) ($MN)   
37 Global miRNA Sequencing and Assay Market Outlook, By Pharmaceutical and Biotechnology Companies (2022-2030) ($MN)  
38 Global miRNA Sequencing and Assay Market Outlook, By Hospitals and Diagnostic Laboratories (2022-2030) ($MN)   
39 Global miRNA Sequencing and Assay Market Outlook, By Contract Research Organizations (CROs) (2022-2030) ($MN)  
40 Global miRNA Sequencing and Assay Market Outlook, By Other End Users (2022-2030) ($MN)     
              
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials